ストックスクリーナーアプリを入手
1.04
1.89%
-0.02
アフターアワーズ：
1.02
-0.02
-1.92%
前日終値:
$1.06
開ける：
$1.02
24時間の取引高:
4,493
Relative Volume:
0.01
時価総額：
$12.20M
収益：
$170.20K
当期純損益:
$-2.78M
株価収益率:
-4.3297
EPS:
-0.2402
ネットキャッシュフロー:
$-2.97M
1週間 パフォーマンス:
-3.70%
1か月 パフォーマンス:
-3.70%
6か月 パフォーマンス:
-46.11%
1年 パフォーマンス:
-62.32%
1日の値動き範囲:
$1.0106
$1.0541
1週間の範囲:
$0.9564
$1.08
52週間の値動き範囲:
$0.7282
$3.68
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Compare GDTC vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
1.04 | 12.44M | 170.20K | -2.78M | -2.97M | -0.2402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cytomed Therapeutics Ltd (GDTC) 最新ニュース
Interview with the Chairman: CytoMed Therapeutics Ltd. (NASDAQ:GDTC) - The Wall Street Transcript
GDTC Technical Analysis & ETF Price Forecast - Intellectia AI
GDTC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
GDTC Should I Buy - Intellectia AI
GDTCCytoMed Therapeutics Ltd Latest Stock News & Market Updates - Stock Titan
CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 1% – Still a Buy? - Defense World
Insider Sell: What analysts say about CytoMed Therapeutics Limited stock2025 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects - Yahoo Finance
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress - Yahoo Finance
Published on: 2026-01-29 21:36:08 - baoquankhu1.vn
Cancer cell therapy company hits back at claims about its first human trial - Stock Titan
CytoMed Therapeutics updates on cell therapy pipeline and trials By Investing.com - Investing.com Nigeria
CytoMed Therapeutics updates on cell therapy pipeline and trials - Investing.com
Biotech seeks investor views on share-based access to cell therapy - Stock Titan
How buybacks impact CytoMed Therapeutics Limited stock valueExit Point & Risk Controlled Daily Plans - Улправда
Is CytoMed Therapeutics Limited stock attractive after correctionJuly 2025 Technicals & Expert-Curated Trade Recommendations - DonanımHaber
How CytoMed Therapeutics Limited (F98) stock performs in volatility spikes2025 Growth vs Value & Fast Entry and Exit Trade Plans - Улправда
Is CytoMed Therapeutics Limited stock a smart buy before Fed meeting2025 Valuation Update & Daily Profit Maximizing Trade Tips - Улправда
CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 7.2% – Here’s Why - Defense World
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
CytoMed stock jumps after announcing clinical trial partnership in Malaysia By Investing.com - Investing.com South Africa
CytoMed stock jumps after announcing clinical trial partnership in Malaysia - Investing.com India
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital - Investing.com
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital By Investing.com - Investing.com South Africa
CytoMed Therapeutics (NASDAQ: GDTC) plans first-in-human gamma delta T cell trial in Malaysia - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) to run first-in-human Malaysia trial of donor-derived γδ T cells - Stock Titan
CytoMed Therapeutics (GDTC) Stock Analysis Report | Financials & Insights - Benzinga
Why CytoMed Therapeutics Limited (F98) stock appears on watchlists2025 Price Momentum & Reliable Trade Execution Plans - Newser
Will CytoMed Therapeutics Limited (F98) stock benefit from Fed rate cuts2025 Short Interest & Intraday High Probability Setup Alerts - Newser
CytoMed acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
CytoMed Therapeutics acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
Applying Wyckoff theory to CytoMed Therapeutics Limited stock2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
What earnings margins imply for CytoMed Therapeutics Limited (F98) stockQuarterly Trade Review & AI Driven Stock Movement Reports - newser.com
How CytoMed Therapeutics Limited stock reacts to job market dataPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Can you recover from losses in CytoMed Therapeutics LimitedTrade Risk Report & AI Driven Stock Reports - newser.com
CytoMed Therapeutics Ltd (GDTC) can make a big difference with a little luck - Setenews
Will CytoMed Therapeutics Limited stock outperform Dow Jones indexJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Why CytoMed Therapeutics Limited stock remains a top recommendationWatch List & Safe Entry Point Identification - newser.com
CytoMed acquires TC BioPharm’s gamma delta T cell technology By Investing.com - Investing.com Canada
How dovish Fed policy supports CytoMed Therapeutics Limited (F98) stock - newser.com
Can CytoMed Therapeutics Limited (F98) stock resist broad market declinesMarket Risk Summary & Daily Profit Focused Stock Screening - newser.com
What insider trading reveals about CytoMed Therapeutics Limited stockQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Will CytoMed Therapeutics Limited (F98) stock maintain strong growthProduct Launch & Stepwise Trade Signal Implementation - newser.com
CytoMed acquires TC BioPharm's gamma delta T cell technology By Investing.com - Investing.com Nigeria
[6-K] CytoMed Therapeutics Ltd Current Report (Foreign Issuer) | GDTC SEC FilingForm 6-K - Stock Titan
Royal Caribbean (NYSE: RCL) launches unsecured notes sale to finance Celebrity Xcel - Stock Titan
Is CytoMed Therapeutics Limited (F98) stock a fit for income portfoliosMarket Risk Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Will CytoMed Therapeutics Limited (F98) stock keep high P E multiples2025 Key Lessons & Weekly Top Stock Performers List - newser.com
Is a relief rally coming for CytoMed Therapeutics Limited holdersMarket Activity Summary & Fast Gain Swing Alerts - newser.com
Cytomed Therapeutics Ltd (GDTC) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):